Showing results (331-340 of 635) with videos related to

Sort By:
Pageof 64
Genetic Testing and Molecular Biomarkers|July 13, 2012
Interaction of the dopaminergic and serotonergic systems significantly influences the risk for multisomatoform disorder: a controlled pilot studyLisa Pahl, Michael Bernateck, Jana Jakobi, et al.
The American Journal of Pathology|December 8, 2004
Chimerism of metanephric adenoma but not of carcinoma in kidney transplantsMichael Mengel, Danny Jonigk, Ludwig Wilkens, et al.
International Journal of Cancer|February 1, 2013
Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic markerSumadi Lukman Anwar, Cord Albat, Till Krech, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|August 22, 2020
Choledochal Cysts Resected during Childhood Show No Mutations of KRAS and BRAF as Early Markers of Malignancy in CholangiocytesMarie Uecker, Ulrich Lehmann, Peter Braubach, et al.
Haematologica|December 18, 2009
Constitutional mismatch repair deficiency and childhood leukemia/lymphoma--report on a novel biallelic MSH6 mutationTim Ripperger, Carmela Beger, Nils Rahner, et al.
Cancer Genetics and Cytogenetics|February 14, 2009
Histopathological criteria and selection algorithms for BRCA1 genetic testingDorothea Gadzicki, Alexandra Schubert, Christine Fischer, et al.
JTO Clinical and Research Reports|July 26, 2022
Brief Report: A Blood-Based MicroRNA Complementary Diagnostic Predicts Immunotherapy Efficacy in Advanced-Sta ge NSCLC With High Programmed Death-Ligand 1 Express ionTimothy Rajakumar, Rastislav Horos, Paul Kittner, et al.
Scientific Reports|July 6, 2017
Mutations in BRCA2 and taxane resistance in prostate cancerCathleen Nientiedt, Martina Heller, Volker Endris, et al.
Oncotarget|September 18, 2014
Co-expression of MET and CD47 is a novel prognosticator for survival of luminal breast cancer patientsIrène Baccelli, Albrecht Stenzinger, Vanessa Vogel, et al.
JCO Precision Oncology|March 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian CancerNicole Pfarr, Karin von Schwarzenberg, Dario Zocholl, et al.
Pageof 64